Navigation Links
Amgen Announces Positive Phase 3 Results for AMG 416 for the Treatment of Secondary Hyperparathyroidism in Patients with Chronic Kidney Disease Receiving Hemodialysis
Date:7/17/2014

-looking statements that are based on the current expectations and beliefs of Amgen Inc. and its subsidiaries (Amgen or us) and are subject to a number of risks, uncertainties and assumptions that could cause actual results to differ materially from those described. All statements, other than statements of historical fact, are statements that could be deemed forward-looking statements, including estimates of revenues, operating margins, capital expenditures, cash, other financial metrics, expected legal, arbitration, political, regulatory or clinical results or practices, customer and prescriber patterns or practices, reimbursement activities and outcomes and other such estimates and results. Forward-looking statements involve significant risks and uncertainties, including those discussed below and more fully described in the Securities and Exchange Commission (SEC) reports filed by Amgen Inc., including Amgen Inc.'s most recent annual report on Form 10-K and any subsequent periodic reports on Form 10-Q and Form 8-K. Please refer to Amgen Inc.'s most recent Forms 10-K, 10-Q and 8-K for additional information on the uncertainties and risk factors related to our business. Unless otherwise noted, Amgen is providing this information as of July 17, 2014, and expressly disclaims any duty to update information contained in this news release.

No forward-looking statement can be guaranteed and actual results may differ materially from those we project. Discovery or identification of new product candidates or development of new indications for existing products cannot be guaranteed and movement from concept to product is uncertain; consequently, there can be no guarantee that any particular product candidate or development of a new indication for an existing product will be successful and become a commercial product. Further, preclinical results do not guarantee safe and effective performance of product candidates in humans. The complexity of the human body cannot be p
'/>"/>

SOURCE Amgen
Copyright©2014 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Mass. General, Broad Institute and Amgen Will Work to Discover New Drugs for Inflammatory Bowel Disease
2. Amgen To Present At The 32nd Annual J.P. Morgan Healthcare Conference
3. Chief Financial Officer Jonathan M. Peacock to Leave Amgen; Company Appoints Michael A. Kelly Acting Chief Financial Officer
4. Amgen Announces Positive Top-Line Results From 52-Week Phase 3 DESCARTES Study Of Evolocumab (AMG 145) In Patients With High Cholesterol
5. Amgen Announces 2014 First Quarter Dividend
6. Amgen To Present At The Oppenheimer 24th Annual Healthcare Conference
7. Amgen To Webcast Investor Meeting At Upcoming American Heart Association Scientific Sessions 2013
8. Amgens Third Quarter 2013 Revenues Increased 10 Percent To $4.7 Billion And Adjusted Earnings Per Share (EPS) Increased 16 Percent To $1.94
9. Amgen Acquires Filgrastim Franchise Rights From Roche In 100 Markets
10. Amgen Successfully Completes Onyx Pharmaceuticals Tender Offer
11. Amgen and Onyx Pharmaceuticals Announce Early Termination of HSR Waiting Period for Amgens Acquisition of Onyx
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/29/2014)... 2014  Moberg ( www.moberg.com ) has received ... medical device used for advanced monitoring of neurological ... a product has met European Union requirements for ... The CNS Monitor captures and analyzes ... waves) to support neurological patient care. The monitor,s ...
(Date:9/29/2014)... , Sept. 29, 2014 EU5 Esophagoscopes ... GlobalData,s new report, "EU5 Esophagoscopes & Gastroscopes ... on the EU5 Esophagoscopes & Gastroscopes market. The ... volume (in units) and average prices (in US ... Flexible Non-Video (Fibre) Gastroscopes and Flexible Video Gastroscopes. ...
(Date:9/29/2014)... September 29, 2014 The global ... billion by 2018, recording a CAGR of 8.8% from ... Devices Market - Global Industry Analysis, Size, Share, Trends ... a U.S.-based market intelligence company. The market, ... from an increasing occurrence of cardiovascular diseases, diabetic retinopathy, ...
Breaking Medicine Technology:Moberg CNS Monitor Receives European CE Mark Approval for Advanced Neurological Monitoring 2EU5 Esophagoscopes & Gastroscopes Market Outlook to 2020 2EU5 Esophagoscopes & Gastroscopes Market Outlook to 2020 3Global Implantable Drug Delivery Devices Market to Grow at 8.8% CAGR to US$ 21.1 billion by 2018: Transparency Market Research 2Global Implantable Drug Delivery Devices Market to Grow at 8.8% CAGR to US$ 21.1 billion by 2018: Transparency Market Research 3Global Implantable Drug Delivery Devices Market to Grow at 8.8% CAGR to US$ 21.1 billion by 2018: Transparency Market Research 4
... MedShape Solutions, Inc, a developer of shape memory orthopedic ... Blair and Tom Hills to the Board of Directors effective ... of experience in the healthcare field, including serving as the ... as the Non-executive Chairman of DJO, Inc., (formerly NYSE-listed sports ...
... Inc. (Pink Sheets: SNDY) is pleased to announce that ... demonstrated at the 95th Annual American College of Surgeons ... During the Breast Ductoscopy for the General Surgeon course, ... hands-on skill stations that will provide the core knowledge ...
Cached Medicine Technology:MedShape Solutions, Inc. Appoints Jack Blair and Tom Hills to Board of Directors; Announces Additions to Management Team 2Solos Endoscopy, Inc.'s MammoView(TM) Product Line to be Demonstrated at the 95th Annual American College of Surgeons Clinical Congress 2
(Date:9/30/2014)... (PRWEB) September 30, 2014 Barbara Williamson ... her amazing memoir "An Extraordinary Life: Love, Sex ... β€œthe messiah of sex,” of the highly successful and ... 1960s and early β€˜70s, the couple started what became ... The clothing-optional, alternate-lifestyle Sandstone Retreat was outrageously popular, with ...
(Date:9/30/2014)... In a move that will ... capture and management functions for sponsors, Synergy Research ... (EDC) system. ClinCapture offers advanced out-of-the-box features that ... clinical trial data and avoid errors and duplications. ... the leading clinical research organization in the Russian ...
(Date:9/30/2014)... 2014 Computer Resources of America, ... based in New York City, has been awarded ... to transform, manage, and support the IT environment ... a leading provider of innovative services that enable ... The contract will cover the four NY-metro ...
(Date:9/30/2014)... September 30, 2014 Miraca Life Sciences ... present eight research posters at the annual meeting of ... will hold its Annual Scientific Meeting and Postgraduate Course ... hall, staff from Miraca Life Sciences will be at ... Clinical Case Challenge. , The research posters for ACG ...
(Date:9/30/2014)... Bibliomotion is proud to announce the release of ... Age by Frank Guglielmo and Sudhanshu Palsule ... apply their leadership coaching experience to introduce Social Leadership – ... behaviors that leaders must adopt in order to thrive in ... a review of The Social Leader in Dialogue Reviews. , ...
Breaking Medicine News(10 mins):Health News:The Autobiography "An Extraordinary Life: Love, Sex and Commitment" Embraces Healthy Sexual Behavior 2Health News:The Autobiography "An Extraordinary Life: Love, Sex and Commitment" Embraces Healthy Sexual Behavior 3Health News:Synergy Research Group Opts for Clinovo 2Health News:Synergy Research Group Opts for Clinovo 3Health News:CRA Awarded Managed Services Contract for Large NYC Nonprofit 2Health News:Miraca Life Sciences Research Institute to Present Eight GI Pathology Research Studies at Annual Meeting of American College of Gastroenterologists 2Health News:The Social Leader: new Bibliomotion book redefines leadership for the Social Age 2Health News:The Social Leader: new Bibliomotion book redefines leadership for the Social Age 3Health News:The Social Leader: new Bibliomotion book redefines leadership for the Social Age 4Health News:The Social Leader: new Bibliomotion book redefines leadership for the Social Age 5Health News:The Social Leader: new Bibliomotion book redefines leadership for the Social Age 6
... Will build upon Research, Care, Advocacy and Education Programs ... YORK, Jan. 29 The Trustees of the Huntington,s ... that Louise Vetter, currently CEO of the American Lung ... Chief Executive Officer, Monday, March 16. In her nine ...
... Mice whose fat cells were allowed to grow larger than fat ... diet, researchers at UT Southwestern Medical Center found in a new ... called collagen VI, which normally surrounds fat cells and limits how ... The findings appear online and in a future edition of ...
... (RA) remains unclear, bioactive proteins known as cytokines, particularly ... a major role in the disease by contributing to ... cytokine, has been thought to be critical for a ... deliver oxygen and nutrients to fetus. A new study ...
... North State Bancorp (OTC,Bulletin Board: NSBC) (the "Company"), ... of $687.6 million as of December 31, 2008,compared to ... an increase,of $140.1 million or 25.6%. , ... December 31, 2008 were $612.7,million and total loans were ...
... babies have complications, without ill effects, study finds , , THURSDAY, ... steroids to babies still in the womb can reduce their ... their growth the way multiple courses can, new research shows. ... of those given a second dose of steroids in utero ...
... Second Annual "For All the Ways You Care" ... of CaregivingWOONSOCKET, R.I., Jan. 29 CVS/pharmacy, the ... annual "For All the Ways You Care" contest ... http://www.newscom.com/cgi-bin/prnh/20090129/NE64371LOGO )CVS/pharmacy invites caregivers and ...
Cached Medicine News:Health News:Louise Vetter joins Huntington's Disease Society of America as new CEO 2Health News:Louise Vetter joins Huntington's Disease Society of America as new CEO 3Health News:UT Southwestern researchers identify protein that may explain 'healthy' obesity 2Health News:Process found to play role in rheumatoid arthritis could lead to new treatment 2Health News:North State Bancorp Reports Profitable 2008 2Health News:North State Bancorp Reports Profitable 2008 3Health News:North State Bancorp Reports Profitable 2008 4Health News:North State Bancorp Reports Profitable 2008 5Health News:North State Bancorp Reports Profitable 2008 6Health News:Additional Steroid Dose May Help Preemies 2Health News:Additional Steroid Dose May Help Preemies 3Health News:CVS/pharmacy Announces National Contest for Stories of Extraordinary Caregiving 2Health News:CVS/pharmacy Announces National Contest for Stories of Extraordinary Caregiving 3
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: